These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 24082345

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J, Milovanovic S, Medarevic D, Dobricic V, Dapčević A, Ibric S.
    Int J Pharm; 2019 Jan 10; 554():190-200. PubMed ID: 30414899
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR, Shelake MR, Shetty SS, Chavan-Patil AB, Pore YV, Late SG.
    J Pharm Pharmacol; 2008 Sep 10; 60(9):1121-9. PubMed ID: 18718114
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
    Liu C, Desai KG.
    Pharm Dev Technol; 2005 Sep 10; 10(4):467-77. PubMed ID: 16370176
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Stability-Enhanced Ternary Solid Dispersions of Glyburide: Effect of Preparation Method on Physicochemical Properties.
    Barghi L, Vekalati A, Jahangiri A.
    Adv Pharmacol Pharm Sci; 2023 Sep 10; 2023():2641153. PubMed ID: 37215486
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Preparation and physicochemical characterization of a solid dispersion of (3, 5, 6-trimethylpyrazin-2-yl) methyl 3-methoxy-4-[(3, 5, 6-trimethylpyrazin-2-yl) methoxy] benzoate (VA-T) and polyvinylpyrrolidone.
    Cao SL, Hou P, Li B, Fu J, Yin XB, Dang XF, Yang CJ, Zhang J, Zhang H, Lei HM, Ni J.
    Chin J Nat Med; 2015 Nov 10; 13(11):861-866. PubMed ID: 26614461
    [Abstract] [Full Text] [Related]

  • 33. Lyophilized Amorphous Dispersion of Telmisartan in a Combined Carrier-Alkalizer System: Formulation Development and In Vivo Study.
    Al-Japairai KAS, Alkhalidi HM, Mahmood S, Almurisi SH, Doolaanea AA, Al-Sindi TA, Chatterjee B.
    ACS Omega; 2020 Dec 22; 5(50):32466-32480. PubMed ID: 33376884
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S, Yue S, Huang Q, Wang W, Yang J, Lan K, Ye L.
    Eur J Drug Metab Pharmacokinet; 2016 Aug 22; 41(4):413-22. PubMed ID: 25669445
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Molecular Disorder of Bicalutamide-Amorphous Solid Dispersions Obtained by Solvent Methods.
    Szafraniec J, Antosik A, Knapik-Kowalczuk J, Gawlak K, Kurek M, Szlęk J, Jamróz W, Paluch M, Jachowicz R.
    Pharmaceutics; 2018 Oct 18; 10(4):. PubMed ID: 30340413
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.